New Pathway, regarded as Tosteson's crowning achievement, has won acclaim among medical students, who worry that the expensive program might suffer under Martin.

"I hope that he keeps things the way they're going right now in terms of the New Pathway," says Sanjay Shetty '96, a first-year medical student. "[It's] the big thing that distinguishes Harvard."

Steven W. Hetts '96, a first-year medical student and a former Winthrop House resident, says he is also interested in hearing Martin's position on affirmative action in medical school admissions.

Unlike many chancellors within the UC system, Martin did not resign when the system's governing board voted to abolish the program within the state universities.

Hetts, a San Francisco native who used to work at UCSF, says he isn't worried about the Medical School's research funding.

"HMS is in the enviable position of getting lots of research money," he says. "It boggles my mind. Other institutions are thinking of shutting down labs, and Harvard just finished the Institutes of Medicine, and the Dana Farber Cancer Center is constructing a new research building."

In order to serve HMS best, Hetts says, Martin should concentrate on getting funding for younger doctors, at the level of associate professor and below